RAPID DEVELOPMENT OF ENHANCED CLEARANCE AFTER HIGH-DOSE CYCLOPHOSPHAMIDE

被引:60
作者
MOORE, MJ
HARDY, RW
THIESSEN, JJ
SOLDIN, SJ
ERLICHMAN, C
机构
[1] UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1038/clpt.1988.203
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:622 / 628
页数:7
相关论文
共 37 条
[1]  
ABRAMSON FP, 1986, DRUG METAB DISPOS, V14, P46
[2]   KINETIC-MODELS OF INDUCTION .1. PERSISTENCE OF THE INDUCING SUBSTANCE [J].
ABRAMSON, FP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (03) :223-228
[3]  
BAGLEY CM, 1973, CANCER RES, V33, P226
[4]   THE SELECTIVE ACTIVATION OF CYTOCHROME-P-450 DEPENDENT MICROSOMAL HYDROXYLASES IN HUMAN AND RAT-LIVER MICROSOMES [J].
BENFORD, DJ ;
BRIDGES, JW ;
BOOBIS, AR ;
KAHN, GC ;
BRODIE, MJ ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (12) :1702-1703
[5]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[6]  
BRECKENRIDGE A, 1973, CLIN PHARMACOL THER, V14, P514
[7]   THE OXAZAPHOSPHORINES [J].
BROCK, N .
CANCER TREATMENT REVIEWS, 1983, 10 :3-15
[8]   ADVERSE EFFECTS OF PHENOBARBITAL ON CORTICOSTEROID METABOLISM IN PATIENTS WITH BRONCHIAL-ASTHMA [J].
BROOKS, SM ;
ACKERMAN, SJ ;
SULLIVAN, I ;
THRASHER, K ;
WERK, EE .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (21) :1125-&
[9]  
COLVIN M, 1976, CANCER RES, V36, P1121
[10]  
CROCHOW LB, 1983, PHARMACOKINETICS ANT, P135